TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Chiron Pharmasynth AS
Closing information (x1000 EUR)
| Closing information | 2019/12 | 2018/12 | 2017/12 |
| Turnover |
1,113
|
702
|
823 |
| Financial expenses |
3
|
5
|
14 |
| Earnings before taxes |
347
|
202
|
457 |
| Total assets |
1,705
|
1,268
|
1,142 |
| Current assets |
1,701
|
1,263
|
1,133 |
| Current liabilities |
509
|
434
|
498 |
| Equity capital |
1,196
|
834
|
644 |
| - share capital |
180
|
177
|
180 |
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Solvency |
70.1%
|
65.8%
|
56.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
31.2%
|
28.8%
|
55.5% |
| Return on assets (ROA) |
20.5%
|
16.3%
|
41.2% |
| Current ratio |
334.2%
|
291.0%
|
227.5% |
| Return on equity (ROE) |
29.0%
|
24.2%
|
71.0% |
| Change turnover |
400
|
-106
|
325 |
| Change turnover % |
56%
|
-13%
|
65% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.